Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-acetylsalicylic acid
- Development stage
- Preclinical
- Lead developer
- Bayer
- Modality
- Small Molecules
- Administration
- Oral, Rectal, Intravenous
01
Overview
5-acetylsalicylic acid, also known as 5-acetyl-2-hydroxybenzoic acid, is a chemical compound exhibiting anti-inflammatory properties. It has been investigated in clinical settings as a potential treatment for inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. While its precise molecular mechanism of action is not fully elucidated, its anti-inflammatory effects suggest involvement in pathways related to inflammation. It is primarily identified as a research chemical and is not listed as an approved pharmaceutical drug for human consumption by suppliers like TargetMol.
- Other names
- 5-acetyl-2-hydroxybenzoic acid
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)COX-3 (Prostaglandin-endoperoxide synthase 1 splice variant)
Beyond the preview
Go deeper on 5-acetylsalicylic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-acetylsalicylic acid.